As of November 14, 2026, IGM Biosciences, Inc. has reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05, the latest filed on March 6, 2025. No WARN notice under its name is on file in the states covered here (Form 8-K, March 6, 2025).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of IGM Biosciences, Inc.
Free to see. No signup.
People from IGM Biosciences, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the IGM Biosciences, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
IGM Biosciences, Inc. reported 4 exit or restructuring plans on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did IGM Biosciences have layoffs in 2025? What its filings say
IGM Biosciences, Inc. (CIK 1496323) reported 4 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K/A filed 2025-03-06
Expected charges
As a result of the 2025 Restructuring, the Company estimates it will incur total restructuring charges between $0.7 million and $2.0 million, consisting of cash expenditures between $4.1 million and $5.4 million for severance and one-time termination costs offset by non-cash compensation and stock-based compensation expense credit of $3.4 million.
Timing
The Company expects to recognize substantially all restructuring charges in the first quarter of 2025.
Form 8-K filed 2025-01-10
This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.
Form 8-K/A filed 2024-11-08
Expected charges
As a result of the 2024 Restructuring, the Company estimates it will incur total restructuring charges between $11.7 million and $14.4 million, consisting of cash expenditures between $3.4 million to $5.7 million for severance and one-time termination costs and between $0.1 million to $0.3 million in contract termination and other costs, along with non-cash incentive and stock-based compensation expense between $8.2 million to $8.4 million.
Timing
The Company expects to recognize substantially all restructuring charges in the third quarter of 2024.
Form 8-K filed 2024-10-03
Timing
The Strategic Pivot activities are expected to be substantially complete in the first quarter of 2025.
Also on the record for IGM Biosciences, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2025 | Stake report, Schedule 13G/A, by Glazer Capital, LLC | — | 5%+ stakes | Source |
| August 18, 2025 | Stake report, Schedule 13D/A, by Baker Bros. Advisors LP | — | 5%+ stakes | Source |
| August 18, 2025 | Stake report, Schedule 13D/A, by Topsoe Holding A/S | — | 5%+ stakes | Source |
| August 15, 2025 | Stake report, Schedule 13D/A, by Redmile Group, LLC | — | 5%+ stakes | Source |
| July 9, 2025 | Stake report, Schedule 13G, by Glazer Capital, LLC | 7.3% of the class | 5%+ stakes | Source |
Keep reading
More on IGM Biosciences, Inc. and the records around it.
Companies that share a holder
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), BeOne Medicines Ltd. (Sep 2026)
- Glazer Capital, LLC also filed stake reports on 108 other companies: Priority Technology Holdings Inc (Nov 2026), Bumble Inc (Oct 2026), Weave Communications Inc (Oct 2026)
Watch IGM Biosciences, Inc.
Get an email when IGM Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with IGM Biosciences, Inc.?
Want the whole picture on IGM Biosciences, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on IGM Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on IGM Biosciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for IGM Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- ICON Technology, Inc.: 114 jobs, Jan 2025 layoff notice within 90 days (2025-01-07)
- ESS Tech, Inc.: 195 jobs, Jun 2025 layoff notice within 90 days (2025-06-03)
- Child Care Associates: 255 jobs, May 2025 layoff notice within 90 days (2025-05-21)
- Cherokee Nation Management & Consulting, LLC.: 5 WARN notices, 81 employees, Mar 2025 layoff notice within 90 days (2025-03-28)
- Metropolis Company: 140 jobs, Jan 2025 layoff notice within 90 days (2025-01-22)
- Rapid Reliable Care by DocGo, LLC: 382 jobs, Mar 2025 layoff notice within 90 days (2025-03-25)
Cite this page
https://mentionfox.com/layoffs/igm-biosciences